May 16, 2018
Idorsia enrols first patient in study to test lucerastat as treatment for Fabry disease
Idorsia has enrolled the first patient in a Phase 3 registration study to investigate the effect of lucerastat, as an…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Fabry disease